CN101454026B - 成像剂 - Google Patents

成像剂 Download PDF

Info

Publication number
CN101454026B
CN101454026B CN2007800192052A CN200780019205A CN101454026B CN 101454026 B CN101454026 B CN 101454026B CN 2007800192052 A CN2007800192052 A CN 2007800192052A CN 200780019205 A CN200780019205 A CN 200780019205A CN 101454026 B CN101454026 B CN 101454026B
Authority
CN
China
Prior art keywords
imaging
chelate
imaging agent
cbp
precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007800192052A
Other languages
English (en)
Chinese (zh)
Other versions
CN101454026A (zh
Inventor
S·彻蒂比
B·纽顿
M·赫斯拜恩
M·索尔巴肯
P·B·艾夫森
R·巴拉
D·克雷默
J·布朗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
GE Healthcare AS
Original Assignee
GE Healthcare Ltd
GE Healthcare AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd, GE Healthcare AS filed Critical GE Healthcare Ltd
Publication of CN101454026A publication Critical patent/CN101454026A/zh
Application granted granted Critical
Publication of CN101454026B publication Critical patent/CN101454026B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CN2007800192052A 2006-05-25 2007-05-25 成像剂 Expired - Fee Related CN101454026B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0610395.6 2006-05-25
GBGB0610395.6A GB0610395D0 (en) 2006-05-25 2006-05-25 Novel imaging agents
PCT/GB2007/001964 WO2007138291A2 (en) 2006-05-25 2007-05-25 Novel imaging agents

Publications (2)

Publication Number Publication Date
CN101454026A CN101454026A (zh) 2009-06-10
CN101454026B true CN101454026B (zh) 2012-12-12

Family

ID=36687722

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800192052A Expired - Fee Related CN101454026B (zh) 2006-05-25 2007-05-25 成像剂

Country Status (8)

Country Link
US (1) US8304388B2 (https=)
EP (1) EP2026844A2 (https=)
JP (1) JP2009537624A (https=)
CN (1) CN101454026B (https=)
BR (1) BRPI0711937A2 (https=)
GB (1) GB0610395D0 (https=)
RU (1) RU2441668C2 (https=)
WO (1) WO2007138291A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5604305B2 (ja) * 2007-12-13 2014-10-08 アンセルム（アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） 線維症の非侵襲性の特異的イメージングのための、ポリペプチド、環状ポリペプチドおよびそれを含む医薬
HRP20190691T1 (hr) 2008-03-27 2019-07-12 Purdue Research Foundation Sintetički peptidoglikani koji vezuju kolagen, priprema, i postupci upotrebe
JP2010215572A (ja) * 2009-03-17 2010-09-30 Japan Health Science Foundation 歯髄炎診断マーカー及び歯髄炎診断システム
WO2011128931A1 (ja) * 2010-04-12 2011-10-20 財団法人ヒューマンサイエンス振興財団 歯髄炎診断マーカー及び歯髄炎診断システム
US9173919B2 (en) * 2011-02-16 2015-11-03 Purdue Research Foundation Collagen-targeted nanoparticles
EP3208278B1 (en) 2011-05-24 2018-10-31 Symic IP, LLC Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
WO2014055253A1 (en) * 2012-10-04 2014-04-10 The General Hospital Corporation Methods of synthesizing and using peg-like fluorochromes
EP4091624A1 (en) 2013-03-15 2022-11-23 Protagonist Therapeutics, Inc. Hepcidin analogues and uses thereof
WO2014144969A1 (en) 2013-03-15 2014-09-18 Purdue Research Foundation Extracellular matrix-binding synthetic peptidoglycans
US20140294902A1 (en) * 2013-04-02 2014-10-02 Protagonist Therapeutics, Inc. Novel a4b7 peptide antagonists
US20140294901A1 (en) * 2013-04-02 2014-10-02 Protagonist Therapeutics, Inc. Novel a4b7 peptide dimer antagonists
WO2015164822A1 (en) 2014-04-25 2015-10-29 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
HRP20211448T1 (hr) 2014-05-16 2021-12-24 Protagonist Therapeutics, Inc. Alfa4beta7 integrin tioeter peptidni antagonisti
CN107206254B (zh) 2014-07-17 2021-08-24 领导医疗有限公司 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途
WO2016054411A1 (en) 2014-10-01 2016-04-07 Protagonist Therapeutics, Inc. NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
US10301371B2 (en) 2014-10-01 2019-05-28 Protagonist Therapeutics, Inc. Cyclic monomer and dimer peptides having integrin antagonist activity
JP6942051B2 (ja) * 2015-01-30 2021-09-29 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション 二量体のコラーゲンハイブリダイゼーションペプチドと使用方法
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US20190002503A1 (en) 2015-12-30 2019-01-03 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
EP3445402A4 (en) * 2016-04-21 2019-12-11 The Board Of Regents Of The University Of Texas System METHOD AND COMPOSITIONS FOR DETECTING ANEURYSMS
AU2018298224B2 (en) 2017-07-07 2024-08-15 Symic Ip, Llc Synthetic bioconjugates
WO2019044894A1 (ja) * 2017-08-31 2019-03-07 学校法人早稲田大学 コラーゲンへの結合活性を有する環状ペプチド
EP3681900A4 (en) 2017-09-11 2021-09-08 Protagonist Therapeutics, Inc. OPIOID AGONIST PEPTIDES AND THEIR USES
CA3089868A1 (en) 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
WO2020014646A1 (en) 2018-07-12 2020-01-16 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
JP7534382B2 (ja) 2019-07-10 2024-08-14 プロタゴニスト セラピューティクス， インコーポレイテッド インターロイキン－２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用
AU2021209086A1 (en) 2020-01-15 2022-08-04 Janssen Biotech, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
CA3167751A1 (en) 2020-01-15 2021-07-22 Janssen Biotech, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
JP7397239B2 (ja) 2020-11-20 2023-12-12 ヤンセン ファーマシューティカ エヌ．ベー． インターロイキン－２３受容体のペプチド阻害剤の組成物
EP4370146A4 (en) 2021-07-14 2025-05-21 Janssen Biotech, Inc. Lipidated peptide inhibitors of the interleukin-23 receptor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972890A (en) * 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
WO1993021226A1 (en) 1992-04-10 1993-10-28 The General Hospital Corporation Cartilage matrix protein and methods for use
US7488792B2 (en) * 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
GB0326546D0 (en) * 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
GB0327494D0 (en) 2003-11-26 2003-12-31 Amersham Plc Novel imaging agents
WO2005082941A1 (en) 2004-02-27 2005-09-09 The University Of Western Ontario Bone sialoprotein collagen-binding peptides
US7575738B2 (en) 2004-08-13 2009-08-18 General Electric Company Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
GB0421308D0 (en) 2004-09-24 2004-10-27 Amersham Plc Enzyme inhibitor imaging agents
DE602005025911D1 (de) * 2004-11-22 2011-02-24 Ge Healthcare As Kontrastmittel für eine extrazelluläre matrix

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Thomas M. Chiang and Andrew H. Kang.A Synthetic Peptide Derived from the Sequence of a Type I Collagen Receptor Inhibits Type I Collagen-mediated Platelet Aggregation.《The Journal of Clinical Investigation》.1997,第100卷(第8期),第2079–2084页. *
THOMAS M. CHIANG.A Synthetic Nonapeptide Derived from the Sequence of a Platelet Type I Collagen Receptor Inhibits Type I Collagen-Mediated Platelet Aggregation.《THE AMERICAN JOURNAL OF THE MEDICAL SCIENCES》.2000,第320卷(第6期),第362-367页. *

Also Published As

Publication number Publication date
GB0610395D0 (en) 2006-07-05
RU2008146031A (ru) 2010-06-27
WO2007138291A2 (en) 2007-12-06
US8304388B2 (en) 2012-11-06
US20090191123A1 (en) 2009-07-30
JP2009537624A (ja) 2009-10-29
BRPI0711937A2 (pt) 2012-07-24
RU2441668C2 (ru) 2012-02-10
WO2007138291A3 (en) 2008-05-29
EP2026844A2 (en) 2009-02-25
CN101454026A (zh) 2009-06-10

Similar Documents

Publication Publication Date Title
CN101454026B (zh) 成像剂
US7226577B2 (en) Gastrin releasing peptide compounds
JP5784911B2 (ja) ボンベシンアナログペプチドアンタゴニスト複合体
RU2594167C2 (ru) Композиции пептидных радиоактивных индикаторов
PT759786E (pt) Conjugados péptido-quelato metálico que se ligam a somatostatina
US20080279765A1 (en) Novel Imaging Agents for Fibrosis
JP2009518372A5 (https=)
AU2003303714B2 (en) Improved linkers for radiopharmaceutical compounds
JP5961191B2 (ja) テクネチウム標識ペプチド
CN101321541A (zh) 用于纤维化的新的成像剂
JP2008514580A (ja) 酵素阻害剤造影剤
US20130189186A1 (en) Apoptosis imaging agents based on lantibiotic peptides
US8834843B2 (en) Imaging method
WO2024153719A1 (en) Dual labelled compounds targeting the prostate specific membrane antigen

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121212

Termination date: 20140525